Chronic Kidney Disease Among Frail Elderly
FRED-CKD
MULTIDISCIPLINARY INTERVENTION FOR FRAIL ELDERLY PATIENTS WITH STAGE 4 or 5 Chronic Kidney Disease (Not on Dialysis)
1 other identifier
interventional
14
1 country
1
Brief Summary
Chronic kidney disease is a common diagnosis in the elderly population and it is associated with significant morbidity and health care costs. The prevalence rates increase with age to about 40% for adults aged \> 65 years. In the elderly population (age 65 and over), CKD is associated with a higher burden of comorbid conditions and frailty. The prevalence of frailty is higher in CKD patients with rated being double in early stages and nearly 6 times higher beyond stage 3b. Previously reported frailty mortality rates of 18% at 3 years and 47% at 7 years comparing with mortality rates in non frail individuals of 3% and 12% respectively. In this study, the investigators investigate the effect of multidisciplinary interventions upon frail elderly patients with CKD not yet on dialysis. This interventions include best medical care, nutrition, physiotherapy, and social, psychological and spiritual support.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 27, 2015
CompletedFirst Posted
Study publicly available on registry
January 30, 2015
CompletedStudy Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2016
CompletedResults Posted
Study results publicly available
May 26, 2021
CompletedMay 26, 2021
May 1, 2021
12 months
January 27, 2015
February 23, 2021
May 24, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mortality
the entire sample will be followed until time of death or until study completed. The cause of death will be determined from proxies or from hospital records.
6 months
Secondary Outcomes (5)
Number of Patients Progressed to the Need for Renal Replacement Therapy (Any Modality or Palliation).
6 months
Hospitalizations
6 months
Physical Functioning Measures
12 weeks
Time up and go
12 weeks
Dominant Hand Grip
12 weeks
Study Arms (2)
multidisciplinary intervention
EXPERIMENTALDue to the problem of randomization, the study became a before and after assessment in the one group that completed the 12 week exercise program and received nutritional support
Non adherence
NO INTERVENTIONThose who were offered the program but did not complete the prescription
Interventions
multidisciplinary intervention
Eligibility Criteria
You may qualify if:
- Eligible participants must be ≥65 years as of December 2014, with estimated glomerular filtration rate (eGFR) of ≤30ml/min, and experiencing frailty defined as 3 out of 5 criterias: unintentional weight loss (self-reported or January 11, 2015 revised objective 10 lbs in past year)
- Self-reported exhaustion
- Weakness (measured by grip strength)
- Slow walking speed (measured by the 6 minute walking test)
- Low physical activity.
You may not qualify if:
- Unable to grasp dynamometer due to various reasons
- Expected life expectancy \<6 months due to a non-renal cause
- Patient refusal to participate
- Plan to travel or transfer treatment site during study period and unable to be contacted
- Severe cognitive impairment (as screened with MoCA \<18).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sameena Iqballead
Study Sites (1)
McGill UNiversity Health Center
Montreal, Quebec, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sameena Iqbal
- Organization
- MUHC
Study Officials
- PRINCIPAL INVESTIGATOR
Sameena Iqbal, MD
McGill University Health Centre/Research Institute of the McGill University Health Centre
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
January 27, 2015
First Posted
January 30, 2015
Study Start
January 1, 2016
Primary Completion
December 15, 2016
Study Completion
December 15, 2016
Last Updated
May 26, 2021
Results First Posted
May 26, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share